<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.3 20210610//EN" "JATS-journalpublishing1-3.dtd">
<article article-type="research-article" dtd-version="1.3" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:lang="ru"><front><journal-meta><journal-id journal-id-type="publisher-id">nefr</journal-id><journal-title-group><journal-title xml:lang="ru">Нефрология</journal-title><trans-title-group xml:lang="en"><trans-title>Nephrology (Saint-Petersburg)</trans-title></trans-title-group></journal-title-group><issn pub-type="ppub">1561-6274</issn><issn pub-type="epub">2541-9439</issn><publisher><publisher-name>Pavlov First Saint-Petersburg State Medical University</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="doi">10.24884/1561-6274-2017-21-5-9-13</article-id><article-id custom-type="elpub" pub-id-type="custom">nefr-291</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="ru"><subject>ОБЗОРЫ И ЛЕКЦИИ</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="en"><subject>REVIEWS AND LECTURES</subject></subj-group></article-categories><title-group><article-title>ФЕРТИЛЬНОСТЬ У ЖЕНЩИН С ТЕРМИНАЛЬНОЙ ПОЧЕЧНОЙ НЕДОСТАТОЧНОСТЬЮ (ОБЗОР ЛИТЕРАТУРЫ)</article-title><trans-title-group xml:lang="en"><trans-title>WOMEN FERTILITY ASSOCIATED WITH END-STAGE CHRONIC RENAL FAILURE (LITERATURE REVIEW)</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Литвинов</surname><given-names>А. С.</given-names></name><name name-style="western" xml:lang="en"><surname>Litvinov</surname><given-names>A. S.</given-names></name></name-alternatives><bio xml:lang="ru"><p>канд. мед. наук, директор,</p><p>344022, Ростовская область, г. Ростов-на-Дону, ул. М. Горького, д. 130, этаж 7</p></bio><bio xml:lang="en"><p>MD, PhD, director,</p><p>344022 Rostov-on-Don, M. Gorkogo st., build. 130, floor 7</p></bio><email xlink:type="simple">sknefc@yandex.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Бисультанова</surname><given-names>З. А.</given-names></name><name name-style="western" xml:lang="en"><surname>Bisultanova</surname><given-names>Z. A.</given-names></name></name-alternatives><bio xml:lang="ru"><p>отделение гинекологии, врач,</p><p>364000, Чеченская Республика, г. Грозный, ул. Социалистическая, д. 4</p></bio><bio xml:lang="en"><p>Department of gynecology, physician,</p><p>364000 Grozniy, Socialist st., build. 4</p></bio><email xlink:type="simple">4gkb@bk.ru</email><xref ref-type="aff" rid="aff-2"/></contrib></contrib-group><aff-alternatives id="aff-1"><aff xml:lang="ru"><institution>Северо-Кавказский нефрологический центр</institution><country>Россия</country></aff><aff xml:lang="en"><institution>North-Caucasian Nephrology Center</institution><country>Russian Federation</country></aff></aff-alternatives><aff-alternatives id="aff-2"><aff xml:lang="ru"><institution>Клиническая больница № 4</institution><country>Россия</country></aff><aff xml:lang="en"><institution>Clinical hospital № 4</institution><country>Russian Federation</country></aff></aff-alternatives><pub-date pub-type="collection"><year>2017</year></pub-date><pub-date pub-type="epub"><day>05</day><month>09</month><year>2017</year></pub-date><volume>21</volume><issue>5</issue><fpage>9</fpage><lpage>13</lpage><permissions><copyright-statement>Copyright &amp;#x00A9; Литвинов А.С., Бисультанова З.А., 2017</copyright-statement><copyright-year>2017</copyright-year><copyright-holder xml:lang="ru">Литвинов А.С., Бисультанова З.А.</copyright-holder><copyright-holder xml:lang="en">Litvinov A.S., Bisultanova Z.A.</copyright-holder><license xml:lang="ru" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>Данная работа распространяется под лицензией Creative Commons Attribution 4.0.</license-p></license><license xml:lang="en" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>This work is licensed under a Creative Commons Attribution 4.0 License.</license-p></license></permissions><self-uri xlink:href="https://journal.nephrolog.ru/jour/article/view/291">https://journal.nephrolog.ru/jour/article/view/291</self-uri><abstract><p>В обзоре представлены современные данные о причинах снижения репродуктивной функции у женщин, получающих заместительную почечную терапию. Был проведен анализ доступных информационных источников и установлена общая характеристика изменений репродуктивной функции женского организма и ассоциация с течением хронической почечной недостаточности. Выявлена прямая зависимость снижения репродуктивной функции женщин в зависимости от вида, длительности и модальности проводимой заместительной почечной терапии. Определены возможные пути повышения фертильности путем выбора альтернативных гемодиализу и гемодиафильтрации методов заместительной почечной терапии. Выявлены этиологические факторы и патогенетические механизмы развития инволютивных изменений в женской репродуктивной системе с указанием влияния на эти изменения нарушенных функций почек, повышенной лекарственной нагрузки и самих параметров процедур заместительной почечной терапии. Установлено, что применение метода трансплантации почки вне зависимости от ее вида (трупная или близкородственная от живого донора) является наиболее оптимальной формой заместительной почечной терапии поддержания и восстановления женской фертильности. Проведены аналогии с развитием гормональных нарушений у женщин без хронической почечной недостаточности и у женщин с терминальной стадией хронической болезни почек. Выделены перспективные направления в изучении женской фертильности при достижении конечной стадии болезни почек и начале диализной терапии.</p></abstract><trans-abstract xml:lang="en"><p>The review presents modern data on the causes of reduced reproductive function in females receiving renal replacement therapy. We conducted an analysis of available information sources and determined the common features of female reproductive function changes and association with chronic renal failure. We revealed direct dependence of women reproductive function decrease from type, duration and modalities of ongoing renal replacement therapy. We identified possible ways to improve fertility through selection of alternative to hemodialysis and hemodiafiltration methods of renal replacement therapy. Revealed etiological factors and pathogenic mechanisms of involutive changes development in the female reproductive system detailing influence on these changes of kidney failure, increased drug loading and the parameters of renal replacement therapy procedures. It is established that the application of the method of renal transplantation, regardless of its type (cadaveric or closely related from a living donor) is the most optimal form of renal replacement therapy to maintain and restore female fertility. We made a comparison of the development of hormonal imbalance in women without chronic renal failure and women with endstage chronic kidney disease. We revealed promising directions in the study of female fertility when reaching end-stage kidney disease and the beginning of dialysis therapy.</p></trans-abstract><kwd-group xml:lang="ru"><kwd>фертильность</kwd><kwd>заместительная почечная терапия</kwd><kwd>хроническая</kwd><kwd>терминальная почечная недостаточность</kwd><kwd>гормоны</kwd><kwd>репродуктивная система</kwd></kwd-group><kwd-group xml:lang="en"><kwd>Fertility</kwd><kwd>renal replacement therapy</kwd><kwd>chronic</kwd><kwd>end stage kidney failure</kwd><kwd>hormones</kwd><kwd>reproductive system</kwd></kwd-group></article-meta></front><back><ref-list><title>References</title><ref id="cit1"><label>1</label><citation-alternatives><mixed-citation xml:lang="ru">Bremer BA, McCauley CR, Wrona RM, Johnson JP. Quality of life in end-stage renal disease: A reexamination. Am J Kidney Dis 1989; (13): 200–209</mixed-citation><mixed-citation xml:lang="en">Bremer BA, McCauley CR, Wrona RM, Johnson JP. Quality of life in end-stage renal disease: A reexamination. Am J Kidney Dis 1989; (13): 200–209</mixed-citation></citation-alternatives></ref><ref id="cit2"><label>2</label><citation-alternatives><mixed-citation xml:lang="ru">Davison SN, Jhangri GS. Impact of pain and symptom burden on the health-related quality of life of hemodialysis patients. J Pain Symptom Manage 2010; (39): 477–485</mixed-citation><mixed-citation xml:lang="en">Davison SN, Jhangri GS. Impact of pain and symptom burden on the health-related quality of life of hemodialysis patients. J Pain Symptom Manage 2010; (39): 477–485</mixed-citation></citation-alternatives></ref><ref id="cit3"><label>3</label><citation-alternatives><mixed-citation xml:lang="ru">Evans RW, Manninen DL, Garrison LP et al. The quality of life of patients with end-stage renal disease. N Engl J Med 1985; (312): 553–559</mixed-citation><mixed-citation xml:lang="en">Evans RW, Manninen DL, Garrison LP et al. The quality of life of patients with end-stage renal disease. N Engl J Med 1985; (312): 553–559</mixed-citation></citation-alternatives></ref><ref id="cit4"><label>4</label><citation-alternatives><mixed-citation xml:lang="ru">Merkus MP, Jager KJ, Dekker FW et al. The Necosad Study Group: Quality of life in patients on chronic dialysis: Selfassessment 3 months after the start of treatment. Am J Kidney Dis 1997; (29): 584–592</mixed-citation><mixed-citation xml:lang="en">Merkus MP, Jager KJ, Dekker FW et al. The Necosad Study Group: Quality of life in patients on chronic dialysis: Selfassessment 3 months after the start of treatment. Am J Kidney Dis 1997; (29): 584–592</mixed-citation></citation-alternatives></ref><ref id="cit5"><label>5</label><citation-alternatives><mixed-citation xml:lang="ru">Mor M, Sevick M, Shields Aet al. Sexual function, activity, and satisfaction among women receiving maintenance hemodialysis. Clin J Am Soc Nephrol 2014; (9): 128–134</mixed-citation><mixed-citation xml:lang="en">Mor M, Sevick M, Shields Aet al. Sexual function, activity, and satisfaction among women receiving maintenance hemodialysis. Clin J Am Soc Nephrol 2014; (9): 128–134</mixed-citation></citation-alternatives></ref><ref id="cit6"><label>6</label><citation-alternatives><mixed-citation xml:lang="ru">US. Renal Data System. USRDS 2012 annual data report: atlas of chronic kidney disease and end-stage renal disease in the United States. Bethesda, MD: National Institute of Health, National Institute of Diabetes and Digestive and Kidney Diseases. 2012</mixed-citation><mixed-citation xml:lang="en">US. Renal Data System. USRDS 2012 annual data report: atlas of chronic kidney disease and end-stage renal disease in the United States. Bethesda, MD: National Institute of Health, National Institute of Diabetes and Digestive and Kidney Diseases. 2012</mixed-citation></citation-alternatives></ref><ref id="cit7"><label>7</label><citation-alternatives><mixed-citation xml:lang="ru">Billips K. Erectile dysfunction as a marker for vascular disease. Curr Urol Rep 2005; (6): 439–444</mixed-citation><mixed-citation xml:lang="en">Billips K. Erectile dysfunction as a marker for vascular disease. Curr Urol Rep 2005; (6): 439–444</mixed-citation></citation-alternatives></ref><ref id="cit8"><label>8</label><citation-alternatives><mixed-citation xml:lang="ru">Navaneethan SD, Vecchio M, Johnson DW et al. Prevalence and correlates of self-reported sexual dysfunction in CKD: A meta-analysis of observational studies. Am J Kidney Dis 2010; (56): 670–685</mixed-citation><mixed-citation xml:lang="en">Navaneethan SD, Vecchio M, Johnson DW et al. Prevalence and correlates of self-reported sexual dysfunction in CKD: A meta-analysis of observational studies. Am J Kidney Dis 2010; (56): 670–685</mixed-citation></citation-alternatives></ref><ref id="cit9"><label>9</label><citation-alternatives><mixed-citation xml:lang="ru">Procci WR, Goldstein DA, Adelstein J, Massry SG. Sexual dysfunction in the male patient with uremia: a reappraisal. Kidney Intl 1981; (19): 317–323</mixed-citation><mixed-citation xml:lang="en">Procci WR, Goldstein DA, Adelstein J, Massry SG. Sexual dysfunction in the male patient with uremia: a reappraisal. Kidney Intl 1981; (19): 317–323</mixed-citation></citation-alternatives></ref><ref id="cit10"><label>10</label><citation-alternatives><mixed-citation xml:lang="ru">Kaufman JM, Hatzichristou DG, Mulhall JP et al. Impotence and chronic kidney failure: a study of the hemodynamic pathophysiology. J Urol 1994; (151): 612–618</mixed-citation><mixed-citation xml:lang="en">Kaufman JM, Hatzichristou DG, Mulhall JP et al. Impotence and chronic kidney failure: a study of the hemodynamic pathophysiology. J Urol 1994; (151): 612–618</mixed-citation></citation-alternatives></ref><ref id="cit11"><label>11</label><citation-alternatives><mixed-citation xml:lang="ru">Reddy SS, Holley JL. The importance of increased dialysis and anemia management for infant survival in pregnant women on hemodialysis. Kidney Int 2009; 75 (11): 1133–1134</mixed-citation><mixed-citation xml:lang="en">Reddy SS, Holley JL. The importance of increased dialysis and anemia management for infant survival in pregnant women on hemodialysis. Kidney Int 2009; 75 (11): 1133–1134</mixed-citation></citation-alternatives></ref><ref id="cit12"><label>12</label><citation-alternatives><mixed-citation xml:lang="ru">Simon J. Testosterone patch increases sexual activity and desire in surgically menopausal women with hypoactive sexual desire disorder. J Clin Endocrinol Metab 2005; (90): 5226–5233</mixed-citation><mixed-citation xml:lang="en">Simon J. Testosterone patch increases sexual activity and desire in surgically menopausal women with hypoactive sexual desire disorder. J Clin Endocrinol Metab 2005; (90): 5226–5233</mixed-citation></citation-alternatives></ref><ref id="cit13"><label>13</label><citation-alternatives><mixed-citation xml:lang="ru">Handelsman DJ. Hypothalamic-pituitary gonadal dysfunction in kidney failure, dialysis and kidney transplantation. Endocr Rev 1985; (6): 151–182</mixed-citation><mixed-citation xml:lang="en">Handelsman DJ. Hypothalamic-pituitary gonadal dysfunction in kidney failure, dialysis and kidney transplantation. Endocr Rev 1985; (6): 151–182</mixed-citation></citation-alternatives></ref><ref id="cit14"><label>14</label><citation-alternatives><mixed-citation xml:lang="ru">Asamiya Y, Otsubo S, Matsuba Y et al. The importance of low blood urea nitrogen levels in pregnant patients undergoing hemodialysis to optimize birth weight and gestational age. Kidney Int 2009; 75 (11): 1217–1222</mixed-citation><mixed-citation xml:lang="en">Asamiya Y, Otsubo S, Matsuba Y et al. The importance of low blood urea nitrogen levels in pregnant patients undergoing hemodialysis to optimize birth weight and gestational age. Kidney Int 2009; 75 (11): 1217–1222</mixed-citation></citation-alternatives></ref><ref id="cit15"><label>15</label><citation-alternatives><mixed-citation xml:lang="ru">Gomez F, de la Cueva R, Wauters J-P, Lemarchand-Beraud T. Endocrine abnormalities in patients undergoing long-term hemodialysis. The role of prolactin. Amer J Med 1980; (68): 522–530</mixed-citation><mixed-citation xml:lang="en">Gomez F, de la Cueva R, Wauters J-P, Lemarchand-Beraud T. Endocrine abnormalities in patients undergoing long-term hemodialysis. The role of prolactin. Amer J Med 1980; (68): 522–530</mixed-citation></citation-alternatives></ref><ref id="cit16"><label>16</label><citation-alternatives><mixed-citation xml:lang="ru">Ayub W, Fletcher S. End stage kidney disease and erectile dysfunction. Is there any hope? Nephrol Dial Transplant 2000; (15): 1525–1528</mixed-citation><mixed-citation xml:lang="en">Ayub W, Fletcher S. End stage kidney disease and erectile dysfunction. Is there any hope? Nephrol Dial Transplant 2000; (15): 1525–1528</mixed-citation></citation-alternatives></ref><ref id="cit17"><label>17</label><citation-alternatives><mixed-citation xml:lang="ru">Niemczyk S, Romejko-Ciepielewska K, Niemczyk L. Adipocytokines and sex hormone disorders in patients with chronic renal failure (CRF). Endokrynol Po 2012; 63 (2): 148-155</mixed-citation><mixed-citation xml:lang="en">Niemczyk S, Romejko-Ciepielewska K, Niemczyk L. Adipocytokines and sex hormone disorders in patients with chronic renal failure (CRF). Endokrynol Po 2012; 63 (2): 148-155</mixed-citation></citation-alternatives></ref><ref id="cit18"><label>18</label><citation-alternatives><mixed-citation xml:lang="ru">Serban C et al. A systematic review and meta-analysis of the effect of statins on plasma asymmetric dimethylarginine concentrations. Sci Rep 2015; (5): 9902</mixed-citation><mixed-citation xml:lang="en">Serban C et al. A systematic review and meta-analysis of the effect of statins on plasma asymmetric dimethylarginine concentrations. Sci Rep 2015; (5): 9902</mixed-citation></citation-alternatives></ref><ref id="cit19"><label>19</label><citation-alternatives><mixed-citation xml:lang="ru">Giovanni FM, Strippoli GF. Sexual Dysfunction in Women with ESRD Requiring Hemodialysis. Clin J Am Soc Nephrol 2012; 7 (6): 974–981</mixed-citation><mixed-citation xml:lang="en">Giovanni FM, Strippoli GF. Sexual Dysfunction in Women with ESRD Requiring Hemodialysis. Clin J Am Soc Nephrol 2012; 7 (6): 974–981</mixed-citation></citation-alternatives></ref><ref id="cit20"><label>20</label><citation-alternatives><mixed-citation xml:lang="ru">Harrington K, Fayyad A, Thakur V et al. The value of uterine artery Doppler in the prediction of uteroplacental complications in multiparous women. Ultrasound Obstet Gynecol 2004; 23 (1): 50–55</mixed-citation><mixed-citation xml:lang="en">Harrington K, Fayyad A, Thakur V et al. The value of uterine artery Doppler in the prediction of uteroplacental complications in multiparous women. Ultrasound Obstet Gynecol 2004; 23 (1): 50–55</mixed-citation></citation-alternatives></ref><ref id="cit21"><label>21</label><citation-alternatives><mixed-citation xml:lang="ru">Nestler JE, Jakubowicz DJ. Decreases in ovarian cytochrome P450c17α activity and serum free testosterone after reduction of insulin secretion in polycystic ovary syndrome. N Engl J Med 1996; (335): 617–623</mixed-citation><mixed-citation xml:lang="en">Nestler JE, Jakubowicz DJ. Decreases in ovarian cytochrome P450c17α activity and serum free testosterone after reduction of insulin secretion in polycystic ovary syndrome. N Engl J Med 1996; (335): 617–623</mixed-citation></citation-alternatives></ref><ref id="cit22"><label>22</label><citation-alternatives><mixed-citation xml:lang="ru">Dachille G. Sexual dysfunction in patients under diaytic treatment. Minerva Urol Nefrol 2006; (58): 195–200</mixed-citation><mixed-citation xml:lang="en">Dachille G. Sexual dysfunction in patients under diaytic treatment. Minerva Urol Nefrol 2006; (58): 195–200</mixed-citation></citation-alternatives></ref><ref id="cit23"><label>23</label><citation-alternatives><mixed-citation xml:lang="ru">Peng Y. Sexual dysfunction in female hemodialysis patients: a multicenter study. Kidney Int 2005; (68): 760–765</mixed-citation><mixed-citation xml:lang="en">Peng Y. Sexual dysfunction in female hemodialysis patients: a multicenter study. Kidney Int 2005; (68): 760–765</mixed-citation></citation-alternatives></ref><ref id="cit24"><label>24</label><citation-alternatives><mixed-citation xml:lang="ru">Boger RH et al. Asymmetric dimethylarginine (ADMA): a novel risk factor for endothelial dysfunction: its role in hypercholesterolemia. Circulation 1998; (98): 1842–1847</mixed-citation><mixed-citation xml:lang="en">Boger RH et al. Asymmetric dimethylarginine (ADMA): a novel risk factor for endothelial dysfunction: its role in hypercholesterolemia. Circulation 1998; (98): 1842–1847</mixed-citation></citation-alternatives></ref><ref id="cit25"><label>25</label><citation-alternatives><mixed-citation xml:lang="ru">Chan CT. Nocturnal hemodialysis: an attempt to correct the ‘unphysiology’ of conventional intermittent renal replacement therapy. Clin Invest Med 2002; 25 (6): 233–235</mixed-citation><mixed-citation xml:lang="en">Chan CT. Nocturnal hemodialysis: an attempt to correct the ‘unphysiology’ of conventional intermittent renal replacement therapy. Clin Invest Med 2002; 25 (6): 233–235</mixed-citation></citation-alternatives></ref><ref id="cit26"><label>26</label><citation-alternatives><mixed-citation xml:lang="ru">Miller JE, Kovesdy CP, Nissenson AR et al. Association of hemodialysis treatment time and dose with mortality and the role of race and sex. Am J Kidney Dis. 2010; (55): 100–112</mixed-citation><mixed-citation xml:lang="en">Miller JE, Kovesdy CP, Nissenson AR et al. Association of hemodialysis treatment time and dose with mortality and the role of race and sex. Am J Kidney Dis. 2010; (55): 100–112</mixed-citation></citation-alternatives></ref><ref id="cit27"><label>27</label><citation-alternatives><mixed-citation xml:lang="ru">Carrero JJ, de Jager DJ, Verduijn M et al. Cardiovascular and noncardiovascular mortality among men and women starting dialysis. Clin J Am Soc Nephrol 2011; (6): 1722–1730</mixed-citation><mixed-citation xml:lang="en">Carrero JJ, de Jager DJ, Verduijn M et al. Cardiovascular and noncardiovascular mortality among men and women starting dialysis. Clin J Am Soc Nephrol 2011; (6): 1722–1730</mixed-citation></citation-alternatives></ref><ref id="cit28"><label>28</label><citation-alternatives><mixed-citation xml:lang="ru">Wang Z, Tang WH, Cho L et al. Targeted metabolomic evaluation of arginine methylation and cardiovascular risks: potential mechanisms beyond nitric oxide synthase inhibition. Arterioscler Thromb Vasc Biol 2009; (29): 1383–1391</mixed-citation><mixed-citation xml:lang="en">Wang Z, Tang WH, Cho L et al. Targeted metabolomic evaluation of arginine methylation and cardiovascular risks: potential mechanisms beyond nitric oxide synthase inhibition. Arterioscler Thromb Vasc Biol 2009; (29): 1383–1391</mixed-citation></citation-alternatives></ref><ref id="cit29"><label>29</label><citation-alternatives><mixed-citation xml:lang="ru">Hladunewich M, Nadeau-Fredette AC, Hercz AE et al. Pregnancy in end stage renal disease. Semin Dial 2011; 24 (6): 634–639</mixed-citation><mixed-citation xml:lang="en">Hladunewich M, Nadeau-Fredette AC, Hercz AE et al. Pregnancy in end stage renal disease. Semin Dial 2011; 24 (6): 634–639</mixed-citation></citation-alternatives></ref><ref id="cit30"><label>30</label><citation-alternatives><mixed-citation xml:lang="ru">Hogas S et al. Predictive Value for Galectin 3 and Cardiotrophin 1 in Hemodialysis Patients. Angiology 2016; (67): 854–859</mixed-citation><mixed-citation xml:lang="en">Hogas S et al. Predictive Value for Galectin 3 and Cardiotrophin 1 in Hemodialysis Patients. Angiology 2016; (67): 854–859</mixed-citation></citation-alternatives></ref><ref id="cit31"><label>31</label><citation-alternatives><mixed-citation xml:lang="ru">Luders C, Castro MC, Titan SM et al. Obstetric outcome in pregnant women on long-term dialysis: a case series. Am J Kidney Dis 2010 56; (1): 77–85</mixed-citation><mixed-citation xml:lang="en">Luders C, Castro MC, Titan SM et al. Obstetric outcome in pregnant women on long-term dialysis: a case series. Am J Kidney Dis 2010 56; (1): 77–85</mixed-citation></citation-alternatives></ref><ref id="cit32"><label>32</label><citation-alternatives><mixed-citation xml:lang="ru">Piccoli GB, Cabiddu G et al. Pregnancy in Chronic Kidney Disease: questions and answers in a changing panorama. Best Pract Res Clin Obstet Gynaecol 2015; 29 (5): 625-642</mixed-citation><mixed-citation xml:lang="en">Piccoli GB, Cabiddu G et al. Pregnancy in Chronic Kidney Disease: questions and answers in a changing panorama. Best Pract Res Clin Obstet Gynaecol 2015; 29 (5): 625-642</mixed-citation></citation-alternatives></ref><ref id="cit33"><label>33</label><citation-alternatives><mixed-citation xml:lang="ru">Прокопенко Е, Никольская И. Беременность у женщин с хронической почечной недостаточностью (ч. 1). Врач 2013; (8): 9–12 [Prokopenko E, Nikolskaia I. Beremennost u zhenshchin s hronicheskoy pochechnoiy nedostatochnostyu (ch. 1). Vrach 2013; (8): 9–12 (in Russ.)]</mixed-citation><mixed-citation xml:lang="en">Прокопенко Е, Никольская И. Беременность у женщин с хронической почечной недостаточностью (ч. 1). Врач 2013; (8): 9–12 [Prokopenko E, Nikolskaia I. Beremennost u zhenshchin s hronicheskoy pochechnoiy nedostatochnostyu (ch. 1). Vrach 2013; (8): 9–12 (in Russ.)]</mixed-citation></citation-alternatives></ref><ref id="cit34"><label>34</label><citation-alternatives><mixed-citation xml:lang="ru">Carrero JJ. Gender differences in chronic kidney disease: underpinnings and therapeutic implications. Kidney Blood Press Res 2010; (33): 383–392</mixed-citation><mixed-citation xml:lang="en">Carrero JJ. Gender differences in chronic kidney disease: underpinnings and therapeutic implications. Kidney Blood Press Res 2010; (33): 383–392</mixed-citation></citation-alternatives></ref><ref id="cit35"><label>35</label><citation-alternatives><mixed-citation xml:lang="ru">Nadeau-Fredette AC, Hladunewich M, Hui D et al. Endstage renal disease and pregnancy. Adv Chronic Kidney Dis 2013 20; (3): 246-252</mixed-citation><mixed-citation xml:lang="en">Nadeau-Fredette AC, Hladunewich M, Hui D et al. Endstage renal disease and pregnancy. Adv Chronic Kidney Dis 2013 20; (3): 246-252</mixed-citation></citation-alternatives></ref><ref id="cit36"><label>36</label><citation-alternatives><mixed-citation xml:lang="ru">Palmer BF, Clegg DJ. Gonadal dysfunction in chronic kidney disease. Rev Endocr Metab Disord 2016; (1): 132-138</mixed-citation><mixed-citation xml:lang="en">Palmer BF, Clegg DJ. Gonadal dysfunction in chronic kidney disease. Rev Endocr Metab Disord 2016; (1): 132-138</mixed-citation></citation-alternatives></ref><ref id="cit37"><label>37</label><citation-alternatives><mixed-citation xml:lang="ru">Rosas SE, Joffe M, Franklin E et al. Prevalence and determinants of erectile dysfunction in hemodialysis patients. Kidney Int 2001; (59): 2259–2266</mixed-citation><mixed-citation xml:lang="en">Rosas SE, Joffe M, Franklin E et al. Prevalence and determinants of erectile dysfunction in hemodialysis patients. Kidney Int 2001; (59): 2259–2266</mixed-citation></citation-alternatives></ref><ref id="cit38"><label>38</label><citation-alternatives><mixed-citation xml:lang="ru">Basok EK, Atsu N, Rifaioglu MM et al. Assessment of female sexual function and quality of life in predialysis, peritoneal dialysis, hemodialysis, and renal transplant patients. Int Urol Nephrol 2009; (41): 473–481</mixed-citation><mixed-citation xml:lang="en">Basok EK, Atsu N, Rifaioglu MM et al. Assessment of female sexual function and quality of life in predialysis, peritoneal dialysis, hemodialysis, and renal transplant patients. Int Urol Nephrol 2009; (41): 473–481</mixed-citation></citation-alternatives></ref><ref id="cit39"><label>39</label><citation-alternatives><mixed-citation xml:lang="ru">Rathi M, Ramachandran R. Sexual and gonadal dysfunction in chronic kidney disease: pathophysiology. Indian J Endocrinol Metab 2012; (16): 214–219</mixed-citation><mixed-citation xml:lang="en">Rathi M, Ramachandran R. Sexual and gonadal dysfunction in chronic kidney disease: pathophysiology. Indian J Endocrinol Metab 2012; (16): 214–219</mixed-citation></citation-alternatives></ref><ref id="cit40"><label>40</label><citation-alternatives><mixed-citation xml:lang="ru">Villar E, Remontet L, Labeeuw M, Ecochard R. Effect of age, gender, and diabetes on excess death in end-stage renal failure. J Am Soc Nephrol 2007; (18): 2125–2134</mixed-citation><mixed-citation xml:lang="en">Villar E, Remontet L, Labeeuw M, Ecochard R. Effect of age, gender, and diabetes on excess death in end-stage renal failure. J Am Soc Nephrol 2007; (18): 2125–2134</mixed-citation></citation-alternatives></ref><ref id="cit41"><label>41</label><citation-alternatives><mixed-citation xml:lang="ru">Stewart-Bentley M, Gans D, Horton R. Regulation of gonadal function in uremia. Metabolism 1974; (23): 1065–1072</mixed-citation><mixed-citation xml:lang="en">Stewart-Bentley M, Gans D, Horton R. Regulation of gonadal function in uremia. Metabolism 1974; (23): 1065–1072</mixed-citation></citation-alternatives></ref><ref id="cit42"><label>42</label><citation-alternatives><mixed-citation xml:lang="ru">Filocamo MT, Zanazzi M, Li Marzi V et al. Sexual dysfunction in women during dialysis and after renal transplantation. J Sex Med 2009; (6): 3125–3131</mixed-citation><mixed-citation xml:lang="en">Filocamo MT, Zanazzi M, Li Marzi V et al. Sexual dysfunction in women during dialysis and after renal transplantation. J Sex Med 2009; (6): 3125–3131</mixed-citation></citation-alternatives></ref><ref id="cit43"><label>43</label><citation-alternatives><mixed-citation xml:lang="ru">Kevenaar ME, Themmen AP, Rivadeneira F et al. A polymorphism in the AMH type II receptor gene is associated with age at menopause in interaction with parity. Hum Reprod 2007 22; (9): 2382-2388</mixed-citation><mixed-citation xml:lang="en">Kevenaar ME, Themmen AP, Rivadeneira F et al. A polymorphism in the AMH type II receptor gene is associated with age at menopause in interaction with parity. Hum Reprod 2007 22; (9): 2382-2388</mixed-citation></citation-alternatives></ref><ref id="cit44"><label>44</label><citation-alternatives><mixed-citation xml:lang="ru">Kielstein JT, Zoccali C. Asymmetric dimethylarginine: a cardiovascular risk factor and a uremic toxin coming of age? Am J Kidney Dis 2015 46; (2): 186-202</mixed-citation><mixed-citation xml:lang="en">Kielstein JT, Zoccali C. Asymmetric dimethylarginine: a cardiovascular risk factor and a uremic toxin coming of age? Am J Kidney Dis 2015 46; (2): 186-202</mixed-citation></citation-alternatives></ref><ref id="cit45"><label>45</label><citation-alternatives><mixed-citation xml:lang="ru">Boger RH, Bode-Boger SM. The clinical pharmacology of L-arginine. Annu Rev Pharmacol Toxicol 2001; (41): 79–99</mixed-citation><mixed-citation xml:lang="en">Boger RH, Bode-Boger SM. The clinical pharmacology of L-arginine. Annu Rev Pharmacol Toxicol 2001; (41): 79–99</mixed-citation></citation-alternatives></ref><ref id="cit46"><label>46</label><citation-alternatives><mixed-citation xml:lang="ru">Seethala S, Hess R, Bossola M et al. Sexual function in women receiving maintenance dialysis. Hemodial Int 2010; (14): 55–60</mixed-citation><mixed-citation xml:lang="en">Seethala S, Hess R, Bossola M et al. Sexual function in women receiving maintenance dialysis. Hemodial Int 2010; (14): 55–60</mixed-citation></citation-alternatives></ref><ref id="cit47"><label>47</label><citation-alternatives><mixed-citation xml:lang="ru">Leong T et al. Asymmetric dimethylarginine independently predicts fatal and nonfatal myocardial infarction and stroke in women – 24-year follow-up of the population study of women in Gothenburg. Arterioscler Thromb Vasc Biol 2008; (28): 961–967</mixed-citation><mixed-citation xml:lang="en">Leong T et al. Asymmetric dimethylarginine independently predicts fatal and nonfatal myocardial infarction and stroke in women – 24-year follow-up of the population study of women in Gothenburg. Arterioscler Thromb Vasc Biol 2008; (28): 961–967</mixed-citation></citation-alternatives></ref><ref id="cit48"><label>48</label><citation-alternatives><mixed-citation xml:lang="ru">Yazici R, Altintepe L, Guney I et al. Female sexual dysfunction in peritoneal dialysis and hemodialysis patients. Ren Fail 2009; (31): 360–364</mixed-citation><mixed-citation xml:lang="en">Yazici R, Altintepe L, Guney I et al. Female sexual dysfunction in peritoneal dialysis and hemodialysis patients. Ren Fail 2009; (31): 360–364</mixed-citation></citation-alternatives></ref><ref id="cit49"><label>49</label><citation-alternatives><mixed-citation xml:lang="ru">Bailie GR, Elder SJ, Mason NA et al. Sexual dysfunction in dialysis patients treated with antihypertensive or antidepressive medications: results from the DOPPS. Nephrol Dial Transplant 2007; 22 (4.): 1163–1170</mixed-citation><mixed-citation xml:lang="en">Bailie GR, Elder SJ, Mason NA et al. Sexual dysfunction in dialysis patients treated with antihypertensive or antidepressive medications: results from the DOPPS. Nephrol Dial Transplant 2007; 22 (4.): 1163–1170</mixed-citation></citation-alternatives></ref><ref id="cit50"><label>50</label><citation-alternatives><mixed-citation xml:lang="ru">Ciaraldi TP, el-Roeiy A et al. Cellular mechanisms of insulin resistance in polycystic ovarian syndrome. J Clin Endocrinol Metab 1992; (75): 577–583</mixed-citation><mixed-citation xml:lang="en">Ciaraldi TP, el-Roeiy A et al. Cellular mechanisms of insulin resistance in polycystic ovarian syndrome. J Clin Endocrinol Metab 1992; (75): 577–583</mixed-citation></citation-alternatives></ref><ref id="cit51"><label>51</label><citation-alternatives><mixed-citation xml:lang="ru">Buckner CL, Wilson L, Papadea CN. An unusual cause of elevated serum total beta hCG. Ann Clin Lab Sci 2007; 37 (2): 186–191</mixed-citation><mixed-citation xml:lang="en">Buckner CL, Wilson L, Papadea CN. An unusual cause of elevated serum total beta hCG. Ann Clin Lab Sci 2007; 37 (2): 186–191</mixed-citation></citation-alternatives></ref><ref id="cit52"><label>52</label><citation-alternatives><mixed-citation xml:lang="ru">Durlinger AL, Kramer P, Karels B et al. Control of primordial follicle recruitment by anti-Müllerian hormone in the mouse ovary. Endocrinology 1999; 140 (12): 5789-5796</mixed-citation><mixed-citation xml:lang="en">Durlinger AL, Kramer P, Karels B et al. Control of primordial follicle recruitment by anti-Müllerian hormone in the mouse ovary. Endocrinology 1999; 140 (12): 5789-5796</mixed-citation></citation-alternatives></ref><ref id="cit53"><label>53</label><citation-alternatives><mixed-citation xml:lang="ru">Furaz-Czerpak KR, Fernandez-Juarez G, Moreno-de la Higuera MA et al. Pregnancy in women on chronic dialysis: a review. Nefrologia 2012; 32 (3): 287–294</mixed-citation><mixed-citation xml:lang="en">Furaz-Czerpak KR, Fernandez-Juarez G, Moreno-de la Higuera MA et al. Pregnancy in women on chronic dialysis: a review. Nefrologia 2012; 32 (3): 287–294</mixed-citation></citation-alternatives></ref><ref id="cit54"><label>54</label><citation-alternatives><mixed-citation xml:lang="ru">Guglielmi KE. Women and ESRD: modalities, survival, unique considerations. Adv Chronic Kidney Dis 2013; 20 (5): 411-418</mixed-citation><mixed-citation xml:lang="en">Guglielmi KE. Women and ESRD: modalities, survival, unique considerations. Adv Chronic Kidney Dis 2013; 20 (5): 411-418</mixed-citation></citation-alternatives></ref><ref id="cit55"><label>55</label><citation-alternatives><mixed-citation xml:lang="ru">Lu TM, Chung MY, Lin CC et al. Asymmetric dimethylarginine and clinical outcomes in chronic kidney disease. Clin J Am Soc Nephrol 2011; (6): 1566–1572</mixed-citation><mixed-citation xml:lang="en">Lu TM, Chung MY, Lin CC et al. Asymmetric dimethylarginine and clinical outcomes in chronic kidney disease. Clin J Am Soc Nephrol 2011; (6): 1566–1572</mixed-citation></citation-alternatives></ref><ref id="cit56"><label>56</label><citation-alternatives><mixed-citation xml:lang="ru">Piccoli GB, Conijn A, Consiglio V et al. Pregnancy in dialysis patients: is the evidence strong enough to lead us to change our counseling policy? Clin J Am Soc Nephrol 2010; 5 (1): 62–71</mixed-citation><mixed-citation xml:lang="en">Piccoli GB, Conijn A, Consiglio V et al. Pregnancy in dialysis patients: is the evidence strong enough to lead us to change our counseling policy? Clin J Am Soc Nephrol 2010; 5 (1): 62–71</mixed-citation></citation-alternatives></ref><ref id="cit57"><label>57</label><citation-alternatives><mixed-citation xml:lang="ru">Ravani P et al. Asymmetrical dimethylarginine predicts progression to dialysis and death in patients with chronic kidney disease: A competing risks modeling approach. Journal of the</mixed-citation><mixed-citation xml:lang="en">Ravani P et al. Asymmetrical dimethylarginine predicts progression to dialysis and death in patients with chronic kidney disease: A competing risks modeling approach. Journal of the</mixed-citation></citation-alternatives></ref><ref id="cit58"><label>58</label><citation-alternatives><mixed-citation xml:lang="ru">American Society of Nephrology 2005; (16): 2449–2455</mixed-citation><mixed-citation xml:lang="en">American Society of Nephrology 2005; (16): 2449–2455</mixed-citation></citation-alternatives></ref><ref id="cit59"><label>59</label><citation-alternatives><mixed-citation xml:lang="ru">Schlesinger S, Sonntag SR, Lieb W, Maas R. Asymmetric and Symmetric Dimethylarginine as Risk Markers for Total Mortality and Cardiovascular Outcomes: A Systematic Review and MetaAnalysis of Prospective Studies. PLoS One 2016; (11): e0165811</mixed-citation><mixed-citation xml:lang="en">Schlesinger S, Sonntag SR, Lieb W, Maas R. Asymmetric and Symmetric Dimethylarginine as Risk Markers for Total Mortality and Cardiovascular Outcomes: A Systematic Review and MetaAnalysis of Prospective Studies. PLoS One 2016; (11): e0165811</mixed-citation></citation-alternatives></ref><ref id="cit60"><label>60</label><citation-alternatives><mixed-citation xml:lang="ru">Toorians A, Janssen E, Laan E et al. Chronic kidney failure and sexual functioning: clinical status versus objectively assessed sexual response. Nephrol Dial Transplant 1997; (12): 2654–2663</mixed-citation><mixed-citation xml:lang="en">Toorians A, Janssen E, Laan E et al. Chronic kidney failure and sexual functioning: clinical status versus objectively assessed sexual response. Nephrol Dial Transplant 1997; (12): 2654–2663</mixed-citation></citation-alternatives></ref><ref id="cit61"><label>61</label><citation-alternatives><mixed-citation xml:lang="ru">Tosi F, Di Sarra D et al. Plasma levels of pentraxin-3, an inflammatory protein involved in fertility, are reduced in women with polycystic ovary syndrome. Eur J Endocrinol 2014; 170 (3): 401-409</mixed-citation><mixed-citation xml:lang="en">Tosi F, Di Sarra D et al. Plasma levels of pentraxin-3, an inflammatory protein involved in fertility, are reduced in women with polycystic ovary syndrome. Eur J Endocrinol 2014; 170 (3): 401-409</mixed-citation></citation-alternatives></ref><ref id="cit62"><label>62</label><citation-alternatives><mixed-citation xml:lang="ru">Никольская ИГ, Новикова СВ, Будыкина ТС и др. Беременность у пациенток с хронической почечной недостаточностью: тактика ведения родоразрешения при консервативно-курабельной стадии. Российский вестник акушера-гинеколога 2012; 12 (6): 21–28 [Nikolskaia IG, Novikova SV, Budykina TS i dr. Beremennost u pacientok s hronicheskoy pochechnoy nedostatochnostyiu: taktika vedeniya rodorazresheniya pri konservativno-kurabelnoy stadii. Rossyiskyi vestnyk akushera-ginekologa 2012; 12 (6): 21–28 (in Russ.)].</mixed-citation><mixed-citation xml:lang="en">Никольская ИГ, Новикова СВ, Будыкина ТС и др. Беременность у пациенток с хронической почечной недостаточностью: тактика ведения родоразрешения при консервативно-курабельной стадии. Российский вестник акушера-гинеколога 2012; 12 (6): 21–28 [Nikolskaia IG, Novikova SV, Budykina TS i dr. Beremennost u pacientok s hronicheskoy pochechnoy nedostatochnostyiu: taktika vedeniya rodorazresheniya pri konservativno-kurabelnoy stadii. Rossyiskyi vestnyk akushera-ginekologa 2012; 12 (6): 21–28 (in Russ.)].</mixed-citation></citation-alternatives></ref><ref id="cit63"><label>63</label><citation-alternatives><mixed-citation xml:lang="ru">van Eps C, Hawley C, Jeffries J et al. Changes in serum prolactin, sex hormones and thyroid function with alternate nightly nocturnal home haemodialysis. Nephrology (Carlton) 2012; 17 (1): 42-47</mixed-citation><mixed-citation xml:lang="en">van Eps C, Hawley C, Jeffries J et al. Changes in serum prolactin, sex hormones and thyroid function with alternate nightly nocturnal home haemodialysis. Nephrology (Carlton) 2012; 17 (1): 42-47</mixed-citation></citation-alternatives></ref><ref id="cit64"><label>64</label><citation-alternatives><mixed-citation xml:lang="ru">Прокопенко Е, Никольская И. Беременность у женщин с хронической почечной недостаточностью (ч. 2). Врач 2013; (8): 13–18 [Prokopenko E, Nikolskaia I. Beremennost u zhenshchin s hronicheskoy pochechnoy nedostatochnostyiu (ch. 2). Vrach 2013; (8): 13–18 (in Russ.)].</mixed-citation><mixed-citation xml:lang="en">Прокопенко Е, Никольская И. Беременность у женщин с хронической почечной недостаточностью (ч. 2). Врач 2013; (8): 13–18 [Prokopenko E, Nikolskaia I. Beremennost u zhenshchin s hronicheskoy pochechnoy nedostatochnostyiu (ch. 2). Vrach 2013; (8): 13–18 (in Russ.)].</mixed-citation></citation-alternatives></ref><ref id="cit65"><label>65</label><citation-alternatives><mixed-citation xml:lang="ru">Pipili C, Grapsa E, Koutsobaili A et al. Pregnancy in dialysis-dependent women – the importance of frequent dialysis and collaborative care: a case report. Hemodial Int 2011; 15 (3): 306–311</mixed-citation><mixed-citation xml:lang="en">Pipili C, Grapsa E, Koutsobaili A et al. Pregnancy in dialysis-dependent women – the importance of frequent dialysis and collaborative care: a case report. Hemodial Int 2011; 15 (3): 306–311</mixed-citation></citation-alternatives></ref><ref id="cit66"><label>66</label><citation-alternatives><mixed-citation xml:lang="ru">Patel SM, Iqbal N et al. Effects of metformin and leuprolide acetate on insulin resistance and testosterone levels in nondiabetic postmenopausal women: a randomized, placebo-controlled trial. Fertil Steril 2010; 94 (6): 2161-2166</mixed-citation><mixed-citation xml:lang="en">Patel SM, Iqbal N et al. Effects of metformin and leuprolide acetate on insulin resistance and testosterone levels in nondiabetic postmenopausal women: a randomized, placebo-controlled trial. Fertil Steril 2010; 94 (6): 2161-2166</mixed-citation></citation-alternatives></ref><ref id="cit67"><label>67</label><citation-alternatives><mixed-citation xml:lang="ru">Panaye M, Jolivot A, Lemoine S et al. Pregnancies in hemodialysis and in patients with end-stage chronic kidney disease: epidemiology, management and prognosis. Nephrol Ther 2014; 10 (7): 485-491</mixed-citation><mixed-citation xml:lang="en">Panaye M, Jolivot A, Lemoine S et al. Pregnancies in hemodialysis and in patients with end-stage chronic kidney disease: epidemiology, management and prognosis. Nephrol Ther 2014; 10 (7): 485-491</mixed-citation></citation-alternatives></ref><ref id="cit68"><label>68</label><citation-alternatives><mixed-citation xml:lang="ru">Konukoglu D, Firtina S, Serin O. The relationship between plasma asymmetrical dimethyl-L-arginine and inflammation and adhesion molecule levels in subjects with normal, impaired, and diabetic glucose tolerance. Metabolism 2008; (57): 110–115</mixed-citation><mixed-citation xml:lang="en">Konukoglu D, Firtina S, Serin O. The relationship between plasma asymmetrical dimethyl-L-arginine and inflammation and adhesion molecule levels in subjects with normal, impaired, and diabetic glucose tolerance. Metabolism 2008; (57): 110–115</mixed-citation></citation-alternatives></ref><ref id="cit69"><label>69</label><citation-alternatives><mixed-citation xml:lang="ru">Dunaif A, Wu X, Lee A, Amanti-Kandarakis E. Defects in insulin receptor signaling in vivo in the polycystic ovary syndrome (PCOS). AJP – Endocrinology and Metabolism 2001; (281): 392–399</mixed-citation><mixed-citation xml:lang="en">Dunaif A, Wu X, Lee A, Amanti-Kandarakis E. Defects in insulin receptor signaling in vivo in the polycystic ovary syndrome (PCOS). AJP – Endocrinology and Metabolism 2001; (281): 392–399</mixed-citation></citation-alternatives></ref><ref id="cit70"><label>70</label><citation-alternatives><mixed-citation xml:lang="ru">Sikora-Grabka E, Adamczak M et al. Serum Anti-Müllerian Hormone Concentration in Young Women with Chronic Kidney Disease on Hemodialysis, and After Successful Kidney Transplantation. Kidney Blood Press Res 2016; 41 (5): 552-560</mixed-citation><mixed-citation xml:lang="en">Sikora-Grabka E, Adamczak M et al. Serum Anti-Müllerian Hormone Concentration in Young Women with Chronic Kidney Disease on Hemodialysis, and After Successful Kidney Transplantation. Kidney Blood Press Res 2016; 41 (5): 552-560</mixed-citation></citation-alternatives></ref></ref-list><fn-group><fn fn-type="conflict"><p>The authors declare that there are no conflicts of interest present.</p></fn></fn-group></back></article>
